Publication Topic

Mitchell M, Taylor A, Lowe K, Langeberg W, Alexander D, Kelsh M, et al. Prevalence of bone metastasis after breast, lung, and prostate cancers: A systematic and quantitative review of the literature. Presented at the 27th Annual Meetings of International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, IL, August 14–17, 2011.

Lau EC, Steffey D, Legg JC, Watson HN, Mowat FS, Kelsh MA. The problem of missing data: Using imputation methods to facilitate oncology outcomes research. Presented at the 27th Annual Meetings of International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, IL, August 14–17, 2011.

Taylor A, Kanas G, Primrose JN, Langeberg WJ, Alexander DD, Kelsh MA, et al. Survival after surgical resection of hepatic metastases from colorectal cancer: An updated review and meta-analysis. Presented at 13th World Congress on Gastrointestinal Cancer, Barcelona Spain, June 22–25, 2011.

Kelsh MA, Kucera G, Erdreich L. Meta-analysis of acoustic neuroma and mobile phone use. Presented at BEMS 33rd Annual Meetings, Halifax, Canada, June 12–17, 2011.

Hess G, Nordyke RJ, Hill J, Hulnick S. 2010. Effect of reimbursement changes on erythropoiesis-stimulating agent utilization and transfusions. Am J Hematol 85(11):838-43; doi: 10.1002/ajh.21837. PMID: 20976794.

Gatto NM, Kelsh MA, Mai DH, Suh M, Proctor DM. 2010. Occupational exposure to hexavalent chromium and cancers of the gastrointestinal tract: A meta-analysis. Cancer Epidemiol 34(4):388-399; doi: 10.1016/j.canep.2010.03.013.

Kelsh MA, Alexander DD, Mink PJ, Mandel JH. 2010. Occupational trichloroethylene exposure and kidney cancer: A meta-analysis. Epidemiology 21(1):95–102; doi: 10.1097/EDE.0b013e3181c30e92. PMID: 20010212.

Kelsh MA, Morimoto L, Lau E. Cancer mortality and oil production in the Amazon region of Ecuador. 2009. Int Arch Occup Environ Health 82(3): 381–395.

Luo W, Nordstrom BL, Fraeman K, Nordyke RJ, Ranganathan G, Linz HE, Winterkorn A, Stokes M, et al. 2008. Adherence to guidelines for use of ESAs in patients with chemotherapy-induced anemia: Results of a retrospective study of an EMR database in the US, 2002-2006. Clin Ther 30(12):2423-35; doi: 10.1016/j.clinthera.2008.12.022. PMID: 19167601.

Nordstrom BL, Weixiu L, Fraeman KH, Whyte JL, Nordyke RJ. 2008. Use of erythropoiesis-stimulating agents among chemotherapy patients with hemoglobin exceeding 12 grams per deciliter. J Manag Care Pharm 14(9):858-69; doi: 10.18553/jmcp.2008.14.9.858. PMID: 19006442.